85 related articles for article (PubMed ID: 2460238)
1. Peripheral blood lymphocytes from patients with cancer lack interleukin-2 (IL-2) receptor expression: isolation of mRNA encoding IL-2R.
Hakim AA
Cancer Detect Prev; 1988; 12(1-6):59-71. PubMed ID: 2460238
[TBL] [Abstract][Full Text] [Related]
2. Peripheral blood lymphocytes from patients with cancer lack interleukin-2 receptors.
Hakim AA
Cancer; 1988 Feb; 61(4):689-701. PubMed ID: 2962732
[TBL] [Abstract][Full Text] [Related]
3. A mechanism by which human breast carcinoma cells escape the host immune system.
Hakim AA
Neoplasma; 1988; 35(6):691-705. PubMed ID: 3265486
[TBL] [Abstract][Full Text] [Related]
4. Effect of interleukin 1 on the expression of interleukin 2 receptor (Tac antigen) on human natural killer cells and natural killer-like cell line (YT cells).
Shirakawa F; Tanaka Y; Eto S; Suzuki H; Yodoi J; Yamashita U
J Immunol; 1986 Jul; 137(2):551-6. PubMed ID: 3013994
[TBL] [Abstract][Full Text] [Related]
5. Interleukin 2 receptor expression by activated HNK-1+ granular lymphocytes: a requirement for their proliferation.
Abo T; Miller CA; Balch CM; Cooper MD
J Immunol; 1983 Oct; 131(4):1822-6. PubMed ID: 6413578
[TBL] [Abstract][Full Text] [Related]
6. TCGF (IL 2)-receptor inducing factor(s). I. Regulation of IL 2 receptor on a natural killer-like cell line (YT cells).
Yodoi J; Teshigawara K; Nikaido T; Fukui K; Noma T; Honjo T; Takigawa M; Sasaki M; Minato N; Tsudo M
J Immunol; 1985 Mar; 134(3):1623-30. PubMed ID: 2578514
[TBL] [Abstract][Full Text] [Related]
7. Interleukin 2 (IL 2) up-regulates its own receptor on a subset of human unprimed peripheral blood lymphocytes and triggers their proliferation.
Harel-Bellan A; Bertoglio J; Quillet A; Marchiol C; Wakasugi H; Mishall Z; Fradelizi D
J Immunol; 1986 Apr; 136(7):2463-9. PubMed ID: 3005412
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of different effects of sera of breast cancer patients on the activity of natural killer cells.
Konjević G; Spuzić I
J Clin Lab Immunol; 1992; 38(2):83-93. PubMed ID: 1343351
[TBL] [Abstract][Full Text] [Related]
9. Down-regulation of IL-18 receptor in cancer patients: its clinical significance.
Kobashi K; Iwagaki H; Yoshino T; Morimoto Y; Kohka H; Kodama M; Nishibori M; Akagi T; Tanaka N
Anticancer Res; 2001; 21(5):3285-93. PubMed ID: 11848485
[TBL] [Abstract][Full Text] [Related]
10. [The effect of sera of breast cancer patients on NK cell activity].
Konjević G; Spuzić I
Srp Arh Celok Lek; 1995; 123(9-10):227-31. PubMed ID: 17974436
[TBL] [Abstract][Full Text] [Related]
11. Role of interleukin-2 (IL-2) in cancer-related immune deficiency: in vitro response to IL-2, production of IL-2, and IL-2 receptor expression in patients with advanced cancer.
Mantovani G; Coiana A; Massidda A; Proto E; Floris C; Macciò A; Pusceddu G; Del Giacco GS
Cancer Detect Prev; 1988; 12(1-6):149-59. PubMed ID: 3263194
[TBL] [Abstract][Full Text] [Related]
12. Rapid Il-2-induced adherence of human natural killer cells. Expression of mRNA for cytokines and IL-2 receptors in adherent NK cells.
Vitolo D; Vujanovic NL; Rabinowich H; Schlesinger M; Herberman RB; Whiteside TL
J Immunol; 1993 Aug; 151(4):1926-37. PubMed ID: 8345189
[TBL] [Abstract][Full Text] [Related]
13. The role of interleukin 2 and T11 E rosette antigen in activation and proliferation of human NK clones.
Schmidt RE; Hercend T; Fox DA; Bensussan A; Bartley G; Daley JF; Schlossman SF; Reinherz EL; Ritz J
J Immunol; 1985 Jul; 135(1):672-8. PubMed ID: 3923116
[TBL] [Abstract][Full Text] [Related]
14. Adult T leukemia cells produce a lymphokine that augments interleukin 2 receptor expression.
Teshigawara K; Maeda M; Nishino K; Nikaido T; Uchiyama T; Tsudo M; Wano Y; Yodoi J
J Mol Cell Immunol; 1985; 2(1):17-26. PubMed ID: 2978223
[TBL] [Abstract][Full Text] [Related]
15. Expression of interleukin-2 receptor alpha (IL-2R alpha) mRNA and protein in advanced epithelial ovarian cancer.
Barton DP; Blanchard DK; Wells AF; Nicosia SV; Roberts WS; Cavanagh D; Djeu JY
Anticancer Res; 1994; 14(3A):761-72. PubMed ID: 8074478
[TBL] [Abstract][Full Text] [Related]
16. Spontaneous expression of the interleukin 2 receptor gene and presence of functional interleukin 2 receptors on T lymphocytes in the blood of individuals with active pulmonary sarcoidosis.
Konishi K; Moller DR; Saltini C; Kirby M; Crystal RG
J Clin Invest; 1988 Sep; 82(3):775-81. PubMed ID: 3138285
[TBL] [Abstract][Full Text] [Related]
17. Increased binding of IL-2 and increased IL-2 receptor mRNA synthesis are expressed by an NK-like cell line in response to IL-1.
Lubinski J; Fong TC; Babbitt JT; Ransone L; Yodoi JJ; Bloom ET
J Immunol; 1988 Mar; 140(6):1903-9. PubMed ID: 2831272
[TBL] [Abstract][Full Text] [Related]
18. Expression of interleukin 2, interferon-gamma, and the IL 2 receptor by human peripheral blood lymphocytes.
Grabstein K; Dower S; Gillis S; Urdal D; Larsen A
J Immunol; 1986 Jun; 136(12):4503-8. PubMed ID: 3086434
[TBL] [Abstract][Full Text] [Related]
19. Progression of natural immunity during one-year treatment of residual disease in neuroblastoma patients with high doses of interleukin-2 after autologous bone marrow transplantation.
Martí F; Pardo N; Peiró M; Bertran E; Amill B; García J; Cubells J; Rueda F
Exp Hematol; 1995 Dec; 23(14):1445-52. PubMed ID: 8542930
[TBL] [Abstract][Full Text] [Related]
20. Distribution of IL-15 receptor alpha-chains on human peripheral blood mononuclear cells and effect of immunosuppressive drugs on receptor expression.
Chae DW; Nosaka Y; Strom TB; Maslinski W
J Immunol; 1996 Oct; 157(7):2813-9. PubMed ID: 8816384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]